| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |